Statistics
Publications
7
Citations
1.4K
H-Index
7
Active since
2014
Camillia S. Azimi is an author at University of California, San Francisco specializing in life sciences, immunology, and cancer immunotherapy.
Publications per year
2014–2025
7
7
Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade
Joy Hsu, Jonathan J. Hodgins, Malvika Marathe et al. · Journal of Clinical Investigation · 2018 · 827 citations · Full text
Life Sciences, Immunology, Oncology +17
Cytokine therapy reverses NK cell anergy in MHC-deficient tumors
Michele Ardolino, Camillia S. Azimi, Alexandre Iannello et al. · Journal of Clinical Investigation · 2014 · 192 citations · Full text
Life Sciences, Immunology, Oncology +17
Naturally occurring T cell mutations enhance engineered T cell therapies
Julie Garcia, Jay Daniels, Yujin Lee et al. · Nature · 2024 · 87 citations · Full text
Life Sciences, Genetics, Immunology +14
1–5 of 7